Erlotinib Treatment in Pretreated Patients With Non-Small Cell Lung Cancer: A Phase II Study

Oncology Letters - Greece
doi 10.3892/ol_00000059
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

A Phase II Trial of Erlotinib Monotherapy for Pretreated Elderly Patients With Advanced EGFR Wild-Type Non-Small Cell Lung Cancer

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2015English

ILD During Erlotinib and Gefitinib Treatment in Japanese Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Randomized Phase II Trial of Seribantumab in Combination With Erlotinib in Patients With EGFR Wild‐Type Non‐Small Cell Lung Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Observational Study on the Efficacy and Safety of Erlotinib in Patients With Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2012English

P3.01-37 Phase II Study of Amrubicin Plus Erlotinib in Previously Treated, Advanced Non-Small Cell Lung Cancer Patients With Wild-Type EGFR: TORG 1320

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Tasisulam Sodium (LY573636 Sodium) as Third-Line Treatment in Patients With Unresectable, Metastatic Non–Small-Cell Lung Cancer: A Phase-Ii Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

A Phase II Study of Oral Etoposide in Elderly Patients With Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1989English

Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients

Korean Journal of Internal Medicine
Internal Medicine
2007English

Erlotinib in Non-Small Cell Lung Cancer Treatment: Current Status and Future Development

Oncologist
Cancer ResearchMedicineOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy